Tumor microenvironment and breast cancer progression

References

• Patocs A, Zhang L, Xu Y, Weber F, Caldes T, Mutter GL, et al. Breast-cancer stromal cells with TP53 mutations and nodal metastases. N Engl J Med 2007; 357:2543 - 51; http://dx.doi.org/10.1056/NEJMoa071825; PMID: 18094375
   PubMed Web of Science ®Google Scholar
• Hu M, Yao J, Cai L, Bachman KE, van den Brûle F, Velculescu V, et al. Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet 2005; 37:899 - 905; http://dx.doi.org/10.1038/ng1596; PMID: 16007089
   PubMed Web of Science ®Google Scholar
• Fiegl H, Millinger S, Goebel G, Müller-Holzner E, Marth C, Laird PW, et al. Breast cancer DNA methylation profiles in cancer cells and tumor stroma: association with HER-2/neu status in primary breast cancer. Cancer Res 2006; 66:29 - 33; http://dx.doi.org/10.1158/0008-5472.CAN-05-2508; PMID: 16397211
   PubMed Web of Science ®Google Scholar
• Shekhar MP, Pauley R, Heppner G. Host microenvironment in breast cancer development: Extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast. Breast Cancer Res 2003; 5:130 - 5; http://dx.doi.org/10.1186/bcr580; PMID: 12793893
   PubMed Web of Science ®Google Scholar
• Bissell MJ, Hall HG, Parry G. How does the extracellular matrix direct gene expression?. J Theor Biol 1982; 99:31 - 68; http://dx.doi.org/10.1016/0022-5193(82)90388-5; PMID: 6892044
   PubMed Web of Science ®Google Scholar
• Bissell MJ, Ram TG. Regulation of functional cytodifferentiation and histogenesis in mammary epithelial cells: role of the extracellular matrix. Environ Health Perspect 1989; 80:61 - 70; http://dx.doi.org/10.1289/ehp.898061; PMID: 2647485
   PubMed Web of Science ®Google Scholar
• Bissell MJ, Barcellos-Hoff MH. The influence of extracellularmatrix on gene expression: is structure the message?. J Cell Sci Suppl 1987; 8:327 - 43; PMID: 3332665
   PubMedGoogle Scholar
• Gehler S, Baldassarre M, Lad Y, Leight JL, Wozniak MA, Riching KM, et al. Filamin A–b1 integrin complex tunes epithelial cell response to matrix tension. Mol Biol Cell 2009; 20:3224 - 38; http://dx.doi.org/10.1091/mbc.E08-12-1186; PMID: 19458194
   PubMed Web of Science ®Google Scholar
• Dvorak HF, Weaver VM, Tlsty T, Bergers G. Tumor microenvironment and progression. J Surg Oncol 2011; 103:468 - 74; http://dx.doi.org/10.1002/jso.21709; PMID: 21480238
   PubMed Web of Science ®Google Scholar
• Maffini MV, Calabro JM, Soto AM, Sonnenschein C. Stromal regulation of neoplastic development: age-dependent normalization of neoplastic mammary cells by mammary stroma. Am J Pathol 2005; 167:1405 - 10; http://dx.doi.org/10.1016/S0002-9440(10)61227-8; PMID: 16251424
   PubMed Web of Science ®Google Scholar
• Bussard KM, Boulanger CA, Booth BW, Bruno RD, Smith GH. Reprogramminghuman cancer cells in the mouse mammary gland. Cancer Res 2010; 70:6336 - 43; http://dx.doi.org/10.1158/0008-5472.CAN-10-0591; PMID: 20647316
   PubMed Web of Science ®Google Scholar
• Maffini MV, Soto AM, Calabro JM, Ucci AA, Sonnenschein C. The stroma as a crucial target in ratmammary gland carcinogenesis. J Cell Sci 2004; 117:1495 - 502; http://dx.doi.org/10.1242/jcs.01000; PMID: 14996910
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57 - 70; http://dx.doi.org/10.1016/S0092-8674(00)81683-9; PMID: 10647931
   PubMed Web of Science ®Google Scholar
• Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009; 30:1073 - 81; http://dx.doi.org/10.1093/carcin/bgp127; PMID: 19468060
   PubMed Web of Science ®Google Scholar
• Polyak K. Breast cancer: origins and evolution. J Clin Invest 2007; 117:3155 - 63; http://dx.doi.org/10.1172/JCI33295; PMID: 17975657
   PubMed Web of Science ®Google Scholar
• Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea–a paradigm shift. Cancer Res 2006; 66:1883 - 90; http://dx.doi.org/10.1158/0008-5472.CAN-05-3153; PMID: 16488983
   PubMed Web of Science ®Google Scholar
• Sgroi DC. Preinvasive breast cancer. Annu Rev Pathol 2010; 5:193 - 221; http://dx.doi.org/10.1146/annurev.pathol.4.110807.092306; PMID: 19824828
   PubMed Web of Science ®Google Scholar
• Hunter KW. Host genetics and tumour metastasis. Br J Cancer 2004; 90:752 - 5; http://dx.doi.org/10.1038/sj.bjc.6601590; PMID: 14970848
   PubMed Web of Science ®Google Scholar
• Weber F, Shen L, Fukino K, Patocs A, Mutter G, Caldés T, et al. Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation. Am J Hum Genet 2006; 78:961 - 72; http://dx.doi.org/10.1086/504090; PMID: 16685647
   PubMed Web of Science ®Google Scholar
• Allred DC, Mohsin SK, Fuqua SA. Histological and biological evolution of human premalignant breast disease. Endocr Relat Cancer 2001; 8:47 - 61; http://dx.doi.org/10.1677/erc.0.0080047; PMID: 11350726
   PubMed Web of Science ®Google Scholar
• Orimo A, Weinberg RA. Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 2006; 5:1597 - 601; http://dx.doi.org/10.4161/cc.5.15.3112; PMID: 16880743
   PubMed Web of Science ®Google Scholar
• Polyak K, Haviv I, Campbell IG. Co-evolution of tumor cells and their microenvironment. Trends Genet 2009; 25:30 - 8; http://dx.doi.org/10.1016/j.tig.2008.10.012; PMID: 19054589
   PubMed Web of Science ®Google Scholar
• Hu M, Polyak K. Microenvironmental regulation of cancer development. Curr Opin Genet Dev 2008; 18:27 - 34; http://dx.doi.org/10.1016/j.gde.2007.12.006; PMID: 18282701
   PubMed Web of Science ®Google Scholar
• Nelson CM, Bissell MJ. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu Rev Cell Dev Biol 2006; 22:287 - 309; http://dx.doi.org/10.1146/annurev.cellbio.22.010305.104315; PMID: 16824016
   PubMed Web of Science ®Google Scholar
• Chin K, de Solorzano CO, Knowles D, Jones A, Chou W, Rodriguez EG, et al. In situ analyses of genome instability in breast cancer. Nat Genet 2004; 36:984 - 8; http://dx.doi.org/10.1038/ng1409; PMID: 15300252
   PubMed Web of Science ®Google Scholar
• Maruyama R, Choudhury S, Kowalczyk A, Bessarabova M, Beresford-Smith B, Conway T, et al. Epigenetic regulation of cell type-specific expression patterns in the human mammary epithelium. PLoS Genet 2011; 7:e1001369; http://dx.doi.org/10.1371/journal.pgen.1001369; PMID: 21533021
   PubMedGoogle Scholar
• Kurose K, Gilley K, Matsumoto S, Watson PH, Zhou XP, Eng C. Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat Genet 2002; 32:355 - 7; http://dx.doi.org/10.1038/ng1013; PMID: 12379854
   PubMed Web of Science ®Google Scholar
• Kurose K, Hoshaw-Woodard S, Adeyinka A, Lemeshow S, Watson PH. Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions. Hum Mol Genet 2001; 10:1907 - 13; http://dx.doi.org/10.1093/hmg/10.18.1907; PMID: 11555627
   PubMed Web of Science ®Google Scholar
• Moinfar F, Man YG, Arnould L, Bratthauer GL, Ratschek M, Tavassoli FA. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res 2000; 60:2562 - 6; PMID: 10811140
   PubMed Web of Science ®Google Scholar
• Qiu W, Hu M, Sridhar A, Opeskin K, Fox S, Shipitsin M, et al. No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas. Nat Genet 2008; 40:650 - 5; http://dx.doi.org/10.1038/ng.117; PMID: 18408720
   PubMed Web of Science ®Google Scholar
• Fukino K, Shen L, Matsumoto S, Morrison CD, Mutter GL, Eng C. Combined Total Genome Loss of Heterozygosity Scan of Breast Cancer Stroma and Epithelium Reveals Multiplicity of Stromal Targets. Cancer Res 2004; 64:7231 - 6; http://dx.doi.org/10.1158/0008-5472.CAN-04-2866; PMID: 15492239
   PubMed Web of Science ®Google Scholar
• Fukino K, Shen L, Patocs A, Mutter GL, Eng C. Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinoma. JAMA 2007; 297:2103 - 11; http://dx.doi.org/10.1001/jama.297.19.2103; PMID: 17507346
   PubMed Web of Science ®Google Scholar
• Weber F, Fukino K, Sawada T, Williams N, Sweet K, Brena RM, et al. Variability in organ-specific EGFR mutational spectra in tumour epithelium and stroma may be the biological basis for differential responses to tyrosine kinase inhibitors. Br J Cancer 2005; 92:1922 - 6; http://dx.doi.org/10.1038/sj.bjc.6602557; PMID: 15841079
   PubMed Web of Science ®Google Scholar
• Weber F, Shen L, Fukino K, Patocs A, Mutter GL, Caldes T, et al. Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation. Am J Hum Genet 2006; 78:961 - 72; http://dx.doi.org/10.1086/504090; PMID: 16685647
   PubMed Web of Science ®Google Scholar
• Hu M, Yao J, Carroll DK, Weremowicz S, Chen H, Carrasco D, et al. Regulation of in situ to invasive breast carcinoma transition. Cancer Cell 2008; 13:394 - 406; http://dx.doi.org/10.1016/j.ccr.2008.03.007; PMID: 18455123
   PubMed Web of Science ®Google Scholar
• Cunha GR, Hayward SW, Wang YZ. Role of stroma in carcinogenesis of the prostate. Differentiation 2002; 70:473 - 85; http://dx.doi.org/10.1046/j.1432-0436.2002.700902.x; PMID: 12492490
   PubMed Web of Science ®Google Scholar
• Barcellos-Hoff MH. The potential influence of radiation-induced microenvironments in neoplastic progression. J Mammary Gland Biol Neoplasia 1998; 3:165 - 75; http://dx.doi.org/10.1023/A:1018794806635; PMID: 10819525
   PubMed Web of Science ®Google Scholar
• Nguyen DH, Oketch-Rabah HA, Illa-Bochaca I, Geyer FC, Reis-Filho JS, Mao JH, et al. Radiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease cancer latency and affect tumor type. Cancer Cell 2011; 19:640 - 51; http://dx.doi.org/10.1016/j.ccr.2011.03.011; PMID: 21575864
   PubMed Web of Science ®Google Scholar
• Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004; 6:17 - 32; http://dx.doi.org/10.1016/j.ccr.2004.06.010; PMID: 15261139
   PubMed Web of Science ®Google Scholar
• Ma XJ, Dahiya S, Richardson E, Erlander M, Sgroi D. Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res 2009; 11:R7; http://dx.doi.org/10.1186/bcr2222; PMID: 19187537
   PubMed Web of Science ®Google Scholar
• Ma XJ, Salunga R, Tuggle JT, Gaudet J, Enright EE, McQuary P, et al. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci USA 2003; 100:5974 - 9; http://dx.doi.org/10.1073/pnas.0931261100; PMID: 12714683
   PubMed Web of Science ®Google Scholar
• Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, et al. Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 2008; 14:518 - 27; http://dx.doi.org/10.1038/nm1764; PMID: 18438415
   PubMed Web of Science ®Google Scholar
• Farmer P, Bonnefoi H, Anderle P, Cameron D, Wirapati P, Becette V, et al. A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nat Med 2009; 15:68 - 74; http://dx.doi.org/10.1038/nm.1908; PMID: 19122658
   PubMed Web of Science ®Google Scholar
• Lerwill MF. Current practical applications of diagnostic immunohistochemistry in breast pathology. Am J Surg Pathol 2004; 28:1076 - 91; http://dx.doi.org/10.1097/01.pas.0000126780.10029.f0; PMID: 15252316
   PubMed Web of Science ®Google Scholar
• Schäfer M, Werner S. Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol 2008; 9:628 - 38; http://dx.doi.org/10.1038/nrm2455; PMID: 18628784
   PubMed Web of Science ®Google Scholar
• Hunter KW, Crawford N, Alsarraj J. Mechanisms of metastasis. Breast Cancer Res 2008; 10:S2; http://dx.doi.org/10.1186/bcr1988; PMID: 19091006
   PubMedGoogle Scholar
• Al-Mehdi AB, Tozawa K, Fisher AB, Shientag L, Lee A, Muschel RJ. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med 2000; 6:100 - 2; http://dx.doi.org/10.1038/71429; PMID: 10613833
   PubMed Web of Science ®Google Scholar
• Hoda SA, Hoda RS, Merlin S, Shamonki J, Rivera M. Issues relating to lymphovascular invasion in breast carcinoma. Adv Anat Pathol 2006; 13:308 - 15; http://dx.doi.org/10.1097/01.pap.0000213048.69564.26; PMID: 17075296
   PubMed Web of Science ®Google Scholar
• Gajdos C, Tartter PI, Bleiweiss IJ. Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers. Ann Surg 1999; 230:692 - 6; http://dx.doi.org/10.1097/00000658-199911000-00012; PMID: 10561094
   PubMed Web of Science ®Google Scholar
• Weiser MR, Montgomery LL, Tan LK, Susnik B, Leung DY, Borgen PI, et al. Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol 2001; 8:145 - 9; http://dx.doi.org/10.1007/s10434-001-0145-y; PMID: 11258779
   PubMed Web of Science ®Google Scholar
• Schoppmann SF, Bayer G, Aumayr K, Taucher S, Geleff S, Rudas M, et al. Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg 2004; 240:306 - 12; http://dx.doi.org/10.1097/01.sla.0000133355.48672.22; PMID: 15273556
   PubMed Web of Science ®Google Scholar
• Woo CS, Silberman H, Nakamura SK, Ye W, Sposto R, Colburn W, et al. Lymph node status combined with lymphovascular invasion creates a more powerful tool for predicting outcome in patients with invasive breast cancer. Am J Surg 2002; 184:337 - 40; http://dx.doi.org/10.1016/S0002-9610(02)00950-9; PMID: 12383896
   PubMed Web of Science ®Google Scholar
• Fisher ER, Anderson S, Tan-Chiu E, Fisher B, Eaton L, Wolmark N. Fifteen-year prognostic discriminants for invasive breast carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol-06. Cancer 2001; 91:1679 - 87; http://dx.doi.org/10.1002/1097-0142(20010415)91:8+<1679::AID-CNCR1183>3.3.CO;2-#; PMID: 11309768
   PubMed Web of Science ®Google Scholar
• El-Gohary YM, Metwally G, Saad RS, Robinson MJ, Mesko T, Poppiti RJ. Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas. Am J Clin Pathol 2008; 129:578 - 86; http://dx.doi.org/10.1309/2HGNJ1GU57JMBJAQ; PMID: 18343785
   PubMed Web of Science ®Google Scholar
• Ejlertsen B, Jensen MB, Rank F, Rasmussen BB, Christiansen P, Kroman N, et al. Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer. J Natl Cancer Inst 2009; 101:729 - 35; http://dx.doi.org/10.1093/jnci/djp090; PMID: 19436035
   PubMed Web of Science ®Google Scholar
• Goetz JG, Minguet S, Navarro-Lérida I, Lazcano JJ, Samaniego R, Calvo E, et al. Biomechanical Remodeling of the Microenvironment by Stromal Caveolin-1Favors Tumor Invasion and metastasis. Cell 2011; 146:148 - 63; http://dx.doi.org/10.1016/j.cell.2011.05.040; PMID: 21729786
   PubMed Web of Science ®Google Scholar
• Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005; 438:820 - 7; http://dx.doi.org/10.1038/nature04186; PMID: 16341007
   PubMed Web of Science ®Google Scholar
• Schedin P, Elias A. Multistep tumorigenesis and the microenvironment. Breast Cancer Res 2004; 6:93 - 101; http://dx.doi.org/10.1186/bcr772; PMID: 14979914
   PubMed Web of Science ®Google Scholar
• Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003; 33:Suppl 245 - 54; http://dx.doi.org/10.1038/ng1089; PMID: 12610534
   PubMed Web of Science ®Google Scholar
• Lin HJL, Zuo T, Lin CH, Kuo CT, Liyanarachchi S, Sun S, et al. Breast cancer-associated fibroblasts confer AKT1-mediated epigenetic silencing of Cystatin M in epithelial cells. Cancer Res 2008; 68:10257 - 66; http://dx.doi.org/10.1158/0008-5472.CAN-08-0288; PMID: 19074894
   PubMed Web of Science ®Google Scholar
• Soares J, Pinto AE, Cunha CV, André S, Barão I, Sousa JM, et al. Global DNA hypomethylation in breast carcinoma: correlation with prognostic factors and tumor progression. Cancer 1999; 85:112 - 8; http://dx.doi.org/10.1002/(SICI)1097-0142(19990101)85:1<112::AID-CNCR16>3.3.CO;2-K; PMID: 9921982
   PubMed Web of Science ®Google Scholar
• Giacinti L, Claudio PP, Lopez M, Giordano A. Epigenetic information and estrogen receptor alpha expression in breast cancer. Oncologist 2006; 11:1 - 8; http://dx.doi.org/10.1634/theoncologist.11-1-1; PMID: 16401708
   PubMed Web of Science ®Google Scholar
• Baylin SB. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2005; 2:Suppl 1 S4 - 11; http://dx.doi.org/10.1038/ncponc0354; PMID: 16341240
   PubMedGoogle Scholar
• Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3:415 - 28; PMID: 12042769
   PubMed Web of Science ®Google Scholar
• Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E, et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 2000; 92:564 - 9; http://dx.doi.org/10.1093/jnci/92.7.564; PMID: 10749912
   PubMed Web of Science ®Google Scholar
• Plachot C, Lelièvre SA. DNA methylation control of tissue polarity and cellular differentiation in the mammary epithelium. Exp Cell Res 2004; 298:122 - 32; http://dx.doi.org/10.1016/j.yexcr.2004.04.024; PMID: 15242767
   PubMed Web of Science ®Google Scholar
• Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001; 1:46 - 54; http://dx.doi.org/10.1038/35094059; PMID: 11900251
   PubMed Web of Science ®Google Scholar
• Dumont N, Wilson MB, Crawford YG, Reynolds PA, Sigaroudinia M, Tlsty TD. Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers. Proc Natl Acad Sci USA 2008; 105:14867 - 72; http://dx.doi.org/10.1073/pnas.0807146105; PMID: 18806226
   PubMed Web of Science ®Google Scholar
• Hu M, Yao J, Cai L, Bachman KE, van den Brule F, Velculescu V, Polyak K, et al. Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet 2005; 37:899 - 905; http://dx.doi.org/10.1038/ng1596; PMID: 16007089
   PubMed Web of Science ®Google Scholar
• Fiegl H, Millinger S, Goebel G, Muller-Holzner E, Marth C, Laird PW, et al. Breast Cancer DNA Methylation Profiles in Cancer Cells and Tumor Stroma: Association with HER-2/neu Status in Primary Breast Cancer. Cancer Res 2006; 66:29 - 33; http://dx.doi.org/10.1158/0008-5472.CAN-05-2508; PMID: 16397211
   PubMed Web of Science ®Google Scholar
• Ruan K, Fang X, Ouyang G. MicroRNAs: Novel regulators in the hallmarks of human cancer. Cancer Lett 2009; 285:116 - 26; http://dx.doi.org/10.1016/j.canlet.2009.04.031; PMID: 19464788
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281 - 97; http://dx.doi.org/10.1016/S0092-8674(04)00045-5; PMID: 14744438
   PubMed Web of Science ®Google Scholar
• He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5:522 - 31; http://dx.doi.org/10.1038/nrg1379; PMID: 15211354
   PubMed Web of Science ®Google Scholar
• Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004; 101:2999 - 3004; http://dx.doi.org/10.1073/pnas.0307323101; PMID: 14973191
   PubMed Web of Science ®Google Scholar
• Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65:7065 - 70; http://dx.doi.org/10.1158/0008-5472.CAN-05-1783; PMID: 16103053
   PubMed Web of Science ®Google Scholar
• Dalmay T, Edwards DR. MicroRNAs and the hallmarks of cancer. Oncogene 2006; 25:6170 - 5; http://dx.doi.org/10.1038/sj.onc.1209911; PMID: 17028596
   PubMed Web of Science ®Google Scholar
• Lujambio A, Ropero S, Ballestar E, Fraga MF, Cerrato C, Setién F, et al. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 2007; 67:1424 - 9; http://dx.doi.org/10.1158/0008-5472.CAN-06-4218; PMID: 17308079
   PubMed Web of Science ®Google Scholar
• Lehmann U, Hasemeier B, Christgen M, Müller M, Römermann D, Länger F, et al. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol 2008; 214:17 - 24; http://dx.doi.org/10.1002/path.2251; PMID: 17948228
   PubMed Web of Science ®Google Scholar
• Corcoran KE, Rameshwar P. Nuclear factor-kappaB accounts for the repressor effects of high stromal cell-derived factor-1alpha levels on Tac1 expression in nontumorigenic breast cells. Mol Cancer Res 2007; 5:373 - 81; http://dx.doi.org/10.1158/1541-7786.MCR-06-0396; PMID: 17409218
   PubMed Web of Science ®Google Scholar
• Patel SA, Heinrich AC, Reddy BY, Srinivas B, Heidaran N, Rameshwar P. Breast cancer biology: the multifaceted roles of mesenchymal stem cells. J Oncol 2008; 425895; PMID: 19277104
   PubMedGoogle Scholar
• Hitchler MJ, Oberley LW, Domann FE. Epigenetic silencing of SOD2 by histone modifications in human breast cancer cells. Free Radic Biol Med 2008; 45:1573 - 80; http://dx.doi.org/10.1016/j.freeradbiomed.2008.09.005; PMID: 18845242
   PubMed Web of Science ®Google Scholar
• Strahl BD, Allis CD. The language of covalent histone modifications. Nature 2000; 403:41 - 5; http://dx.doi.org/10.1038/47412; PMID: 10638745
   PubMed Web of Science ®Google Scholar
• Sandal T, Valyi-Nagy K, Spencer VA, Folberg R, Bissell MJ, Maniotis AJ. Epigenetic reversion of breast carcinoma phenotype is accompanied by changes in DNA sequestration as measured by AluI restriction enzyme. Am J Pathol 2007; 170:1739 - 49; http://dx.doi.org/10.2353/ajpath.2007.060922; PMID: 17456778
   PubMed Web of Science ®Google Scholar
• Florin L, Maas-Szabowski N, Werner S, Szabowski A, Angel P. Increased keratinocyte proliferation by JUN-dependent expression of PTN and SDF-1 in fibroblasts. J Cell Sci 2005; 118:1981 - 9; http://dx.doi.org/10.1242/jcs.02303; PMID: 15840658
   PubMed Web of Science ®Google Scholar
• Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003; 83:835 - 70; PMID: 12843410
   PubMed Web of Science ®Google Scholar
• Sibilia M, Kroismayr R, Lichtenberger BM, Natarajan A, Hecking M, Holcmann M. The epidermal growth factor receptor: from development to tumorigenesis. Differentiation 2007; 75:770 - 87; http://dx.doi.org/10.1111/j.1432-0436.2007.00238.x; PMID: 17999740
   PubMed Web of Science ®Google Scholar
• Wakefield LM, Roberts AB. TGF-beta signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 2002; 12:22 - 9; http://dx.doi.org/10.1016/S0959-437X(01)00259-3; PMID: 11790550
   PubMed Web of Science ®Google Scholar
• Yu JL, Rak J. Host microenvironment in breast cancer development: Inflammatory and immune cells in tumour angiogenesis and arteriogenesis. Breast Cancer Res 2003; 5:83 - 8; http://dx.doi.org/10.1186/bcr573; PMID: 12631386
   PubMed Web of Science ®Google Scholar
• Lin EY, Pollard JW. Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res 2007; 67:5064 - 6; http://dx.doi.org/10.1158/0008-5472.CAN-07-0912; PMID: 17545580
   PubMed Web of Science ®Google Scholar
• Lewis CE, Hughes R. Inflammation and breast cancer. Microenvironmental factors regulating macrophage function in breast tumours: hypoxia and angiopoietin-2. Breast Cancer Res 2007; 9:209; http://dx.doi.org/10.1186/bcr1679; PMID: 17601353
   PubMed Web of Science ®Google Scholar
• Ben-Baruch A. Inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions. . Breast Cancer Res 2003; 5:31 - 36; http://dx.doi.org/10.1186/bcr554; PMID: 12559043
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420:860 - 7; http://dx.doi.org/10.1038/nature01322; PMID: 12490959
   PubMed Web of Science ®Google Scholar
• Klaunig JE, Kamendulis LM. The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 2004; 44:239 - 67; http://dx.doi.org/10.1146/annurev.pharmtox.44.101802.121851; PMID: 14744246
   PubMed Web of Science ®Google Scholar
• Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006; 160:1 - 40; http://dx.doi.org/10.1016/j.cbi.2005.12.009; PMID: 16430879
   PubMed Web of Science ®Google Scholar
• Roberts RA, Laskin DL, Smith CV, Robertson FM, Allen EMG, Doorn JA, et al. Nitrative and oxidative stress in toxicology and disease. Toxicol Sci 2009; 112:4 - 16; http://dx.doi.org/10.1093/toxsci/kfp179; PMID: 19656995
   PubMed Web of Science ®Google Scholar
• Curtis CD, Thorngren DL, Nardulli AM. Immunohistochemical analysis of oxidative stress and DNA repair proteins in normal mammary and breast cancer tissue. BMC Cancer 2010; 10:9; http://dx.doi.org/10.1186/1471-2407-10-9; PMID: 20064251
   PubMed Web of Science ®Google Scholar
• Schultz-Norton JR, McDonald WH, Yates JR, Nardulli AM. Protein disulfide isomerase serves as a molecular chaperone to maintain estrogen receptor alpha structure and function. Mol Endocrinol 2006; 20:1982 - 95; http://dx.doi.org/10.1210/me.2006-0006; PMID: 16690750
   PubMed Web of Science ®Google Scholar
• Rao AK, Ziegler YS, McLeod IX, Yates JR, Nardulli AM. Effects of Cu/Zn superoxide dismutase on estrogen responsiveness and oxidative stress in human breast cancer cells. Mol Endocrinol 2008; 22:1113 - 24; http://dx.doi.org/10.1210/me.2007-0381; PMID: 18258688
   PubMed Web of Science ®Google Scholar
• Rao AK, Ziegler YS, McLeod IX, Yates JR, Nardulli AM. Thioredoxin and thioredoxin reductase influence estrogen receptor alpha-mediated gene expression in human breast cancer cells. J Mol Endocrinol 2009; 43:251 - 61; http://dx.doi.org/10.1677/JME-09-0053; PMID: 19620238
   PubMed Web of Science ®Google Scholar
• Curtis CD, Thorngren DL, Ziegler YS, Sarkeshik A, Yates JR, Nardulli AM. Apurinic/apyrimidinic endonuclease 1 alters estrogen receptor activity and estrogen-responsive gene expression. Mol Endocrinol 2009; 23:1346 - 59; http://dx.doi.org/10.1210/me.2009-0093; PMID: 19460860
   PubMed Web of Science ®Google Scholar
• Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86:353 - 64; http://dx.doi.org/10.1016/S0092-8674(00)80108-7; PMID: 8756718
   PubMed Web of Science ®Google Scholar
• Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol 2006; 39:469 - 78; http://dx.doi.org/10.5483/BMBRep.2006.39.5.469; PMID: 17002866
   PubMedGoogle Scholar
• Augustin HG, Koh GY, Thurston G, Alitalo K. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 2009; 10:165 - 77; http://dx.doi.org/10.1038/nrm2639; PMID: 19234476
   PubMed Web of Science ®Google Scholar
• Lohela M, Bry M, Tammela T, Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol 2009; 21:154 - 65; http://dx.doi.org/10.1016/j.ceb.2008.12.012; PMID: 19230644
   PubMed Web of Science ®Google Scholar
• Saharinen P, Bry M, Alitalo K. How do angiopoietins Tie in with vascular endothelial growth factors?. Curr Opin Hematol 2010; 17:198 - 205; PMID: 20375888
   PubMed Web of Science ®Google Scholar
• Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003; 3:401 - 10; http://dx.doi.org/10.1038/nrc1093; PMID: 12778130
   PubMed Web of Science ®Google Scholar
• Acevedo VD, Ittmann M, Spencer DM. Paths of FGFR-driven tumorigenesis. Cell Cycle 2009; 8:580 - 8; http://dx.doi.org/10.4161/cc.8.4.7657; PMID: 19182515
   PubMed Web of Science ®Google Scholar
• Ciruna B, Rossant J. FGF Signaling Regulates Mesoderm Cell Fate Specification and Morphogenetic Movement at the Primitive Streak. Dev Cell 2001; 1:37 - 49; http://dx.doi.org/10.1016/S1534-5807(01)00017-X; PMID: 11703922
   PubMed Web of Science ®Google Scholar
• Mezquita B, Mezquita J, Pau M, Mezquita C. A novel intracellular isoform of VEGFR-1 activates Src and promotes cell invasion in MDA-MB-231 breast cancer cells. J Cell Biochem 2010; 110:732 - 42; http://dx.doi.org/10.1002/jcb.22584; PMID: 20512933
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008; 454:436 - 44; http://dx.doi.org/10.1038/nature07205; PMID: 18650914
   PubMed Web of Science ®Google Scholar
• Soucek L, Lawlor ER, Soto D, Shchors K, Swigart LB, Evan GI. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat Med 2007; 13:1211 - 8; http://dx.doi.org/10.1038/nm1649; PMID: 17906636
   PubMed Web of Science ®Google Scholar
• Sparmann A, Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 2004; 6:447 - 58; http://dx.doi.org/10.1016/j.ccr.2004.09.028; PMID: 15542429
   PubMed Web of Science ®Google Scholar
• Vakkila J, Lotze MT. Inflammation and necrosis promote tumour growth. Nat Rev Immunol 2004; 4:641 - 8; http://dx.doi.org/10.1038/nri1415; PMID: 15286730
   PubMed Web of Science ®Google Scholar
• Zong WX, Thompson CB. Necrotic death as a cell fate. Genes Dev 2006; 20:1 - 15; http://dx.doi.org/10.1101/gad.1376506; PMID: 16391229
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140:883 - 99; http://dx.doi.org/10.1016/j.cell.2010.01.025; PMID: 20303878
   PubMed Web of Science ®Google Scholar
• Murdoch C, Giannoudis A, Lewis CE. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 2004; 104:2224 - 34; http://dx.doi.org/10.1182/blood-2004-03-1109; PMID: 15231578
   PubMed Web of Science ®Google Scholar
• Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN. Cancer Cell 2009; 16:183 - 94; http://dx.doi.org/10.1016/j.ccr.2009.06.017; PMID: 19732719
   PubMed Web of Science ®Google Scholar
• Moreno-Bueno G, Portillo F, Cano A. Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 2008; 27:6958 - 69; http://dx.doi.org/10.1038/onc.2008.346; PMID: 19029937
   PubMed Web of Science ®Google Scholar
• Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 2007; 8:221 - 33; http://dx.doi.org/10.1038/nrm2125; PMID: 17318226
   PubMed Web of Science ®Google Scholar
• Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006; 69:562 - 73; http://dx.doi.org/10.1016/j.cardiores.2005.12.002; PMID: 16405877
   PubMed Web of Science ®Google Scholar
• Köhrmann A, Kammerer U, Kapp M, Dietl J, Anacker J. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature. BMC Cancer 2009; 9:188; http://dx.doi.org/10.1186/1471-2407-9-188; PMID: 19531263
   PubMed Web of Science ®Google Scholar
• Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010; 141:52 - 67; http://dx.doi.org/10.1016/j.cell.2010.03.015; PMID: 20371345
   PubMed Web of Science ®Google Scholar
• Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 2000; 14:163 - 76; PMID: 10652271
   PubMed Web of Science ®Google Scholar
• Li JR, Li MQ, Bao JT, Li JZ. Correlation between expression of metastasis-associated gene 1 and matrix metalloproteinase 9 and invasion and metastasis of breast cancer. Zhonghua Yi Xue Za Zhi 2008; 88:2278 - 80; PMID: 19087679
   PubMedGoogle Scholar
• Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000; 2:737 - 44; http://dx.doi.org/10.1038/35036374; PMID: 11025665
   PubMed Web of Science ®Google Scholar
• Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE, et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 2005; 436:123 - 7; http://dx.doi.org/10.1038/nature03688; PMID: 16001073
   PubMed Web of Science ®Google Scholar
• Jeon HW, Lee YM. Inhibition of histone deacetylase attenuates hypoxia-induced migration and invasion of cancer cells via the restoration of RECK expression. Mol Cancer Ther 2010; 9:1361 - 70; http://dx.doi.org/10.1158/1535-7163.MCT-09-0717; PMID: 20442303
   PubMed Web of Science ®Google Scholar
• Chang HY, Sneddon JB, Alizadeh AA, Sood R, West RB, Montgomery K, et al. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol 2004; 2:E7; http://dx.doi.org/10.1371/journal.pbio.0020007; PMID: 14737219
   PubMed Web of Science ®Google Scholar
• Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315:1650 - 9; PMID: 3537791
   PubMed Web of Science ®Google Scholar
• Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999; 59:5002 - 11; PMID: 10519415
   PubMed Web of Science ®Google Scholar
• Bhowmick NA, Moses HL. Tumor-stroma interactions. Curr Opin Genet Dev 2005; 15:97 - 101; http://dx.doi.org/10.1016/j.gde.2004.12.003; PMID: 15661539
   PubMed Web of Science ®Google Scholar
• Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007; 449:557 - 63; http://dx.doi.org/10.1038/nature06188; PMID: 17914389
   PubMed Web of Science ®Google Scholar
• Tlsty TD, Coussens LM. Tumor stroma and regulation of cancer development. Annu Rev Pathol 2006; 1:119 - 50; http://dx.doi.org/10.1146/annurev.pathol.1.110304.100224; PMID: 18039110
   PubMed Web of Science ®Google Scholar
• Bergamaschi A, Tagliabue E, Sørlie T, Naume B, Triulzi T, Orlandi R, et al. Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome. J Pathol 2008; 214:357 - 67; http://dx.doi.org/10.1002/path.2278; PMID: 18044827
   PubMed Web of Science ®Google Scholar
• Rajski M, Zanetti-Dällenbach R, Vogel B, Herrmann R, Rochlitz C, Buess M. IGF-I induced genes in stromal fibroblasts predict the clinical outcome of breast and lung cancer patients. BMC Med 2010; 8:1; http://dx.doi.org/10.1186/1741-7015-8-1; PMID: 20051100
   PubMed Web of Science ®Google Scholar
• Sharma M, Beck AH, Webster JA, Espinosa I, Montgomery K, Varma S, et al. Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ. Breast Cancer Res Treat 2010; 123:397 - 404; http://dx.doi.org/10.1007/s10549-009-0654-0; PMID: 19949854
   PubMed Web of Science ®Google Scholar